The stock of LifeStance Health Group Inc. (NASDAQ:LFST) decreased by -$0.09 on Friday to finish at $8.16, down -1.09 percent. The last five days have seen an average of 1,083,560 shares of common stock traded. 33 times new highs were reached in the current year, with a gain of $3.22. The average number of shares traded over the last 20 days was 751,350, while the average volume over the last 50 days totaled 876,172.
LFST stock dropped -7.06% since last month. On 08/10/23, the company’s shares reached a one-month low of $7.97. The stock touched a high of $10.50 on 06/29/23, after rallying from a low of $4.22 in 52 weeks. The price of LFST stock has risen by 65.18% or $3.22 this year, reaching a new high 33 times. Still, the stock price is down -22.29% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
LFST stock investors should be aware that LifeStance Health Group Inc. (LFST) stock had its last reported insider trading activity 39 days ago on Jul 06. On Jul 06, Chief Development Officer Mullins Kevin Michael sold 135,400 shares at $8.67 each. This transaction resulted in the insider making $1,173,918. On Jul 05, Mullins Kevin Michael sold 150,000 shares at a price of US$8.72. After the transaction, the insider now owns 5,166,016 shares. Chief Development Officer Mullins Kevin Michael had earlier sold 54,600 shares on Jul 03 for $9.00 a share. The transaction was completed for $491,400.
Valuation Metrics
Beta for the stock is 0.99. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 3.42, the price-to-book (PB) ratio of 1.98.
Financial Health
For the three months ended June 29, LifeStance Health Group Inc.’s quick ratio was 1.30, while its current ratio was 1.30, indicating its ability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.17, and the total debt to equity ratio is 0.17. LifeStance Health Group Inc.’s EBITDA margin for the year ended June 29 was -15.93%, whereas its operating margin stood at -18.50% for the same period. Based on annual data, it had gross profit of $237.02 million and revenue of $859.54 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. LFST’s return on assets (ROA) during the last 12 months has been -7.70%. There was a -11.70% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was -10.90%.
Earnings Surprise
According to LifeStance Health Group Inc.’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $259.58 million, while revenues rose by 19.28% to $252.59 million. It was predicted that LifeStance Health Group Inc.’s quarterly earnings would be -$0.13, but it ended up being -$0.09, beating the consensus by -44.40%. EBITDA was -$28.36 million for the quarter. At the end of LifeStance Health Group Inc.’s most recent quarter ended June 29, its liabilities totaled 676.04 million, while its total debt was $500.34 million. Equity owned by shareholders amounts to $378.0 million.
Technical Picture
Here’s a quick look at LifeStance Health Group Inc.’s (LFST) price momentum from a technical perspective. As of 11 August, the RSI 9-day stood at 29.18%, suggesting the stock is oversold, with a 38.80% historical volatility rate.
The stochastic %K and %D were 11.57% and 12.24% respectively, while the average true range (ATR) was 0.36. Based on the 14-day stochastic reading of 12.42%, the RSI (14) reading is 35.04%. On the 9-day MACD Oscillator, the stock is at -0.60, and the 14-day reading is at -0.75.
Analyst Ratings
LifeStance Health Group Inc. (NASDAQ: LFST) was downgraded by TD Cowen to a a Market perform rating in its latest research report. The stock was previously rated as a an Outperform.
What is LFST’s price target for the next 12 months?
The current consensus forecast for the stock is between $9.00 and $10.00, with a median target price of $9.75. In analyzing these forecasts, the average price target given by analysts for LifeStance Health Group Inc. (LFST) is $9.58.
